Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2015

01-06-2015 | Original Article

Prevalence of Advanced Colorectal Neoplasm After Kidney Transplantation: Surveillance Based on the Results of Screening Colonoscopy

Authors: Jee Hye Kwon, Seong-Joon Koh, Ji Yeon Kim, Ji Won Kim, Kook Lae Lee, Byeong Gwan Kim, Jong Pil Im, Joo Sung Kim

Published in: Digestive Diseases and Sciences | Issue 6/2015

Login to get access

Abstract

Background and Aim

The aim of this study was to determine whether the prevalence of advanced colorectal neoplasms increases in kidney transplant recipients and to define the appropriate duration for surveillance colonoscopy after kidney transplantation (TPL).

Methods

Our study consisted of 248 kidney transplant patients who underwent a colonoscopy at Seoul National University Hospital from 1996 to 2008. For each patient, two or more age- and sex-matched controls were identified from a population of asymptomatic individuals.

Results

Twenty (8.1 %) patients had advanced colonic neoplasms, including colorectal cancers (four patients, 1.6 %), after kidney TPL. A case–control study showed that the odds of advanced colonic neoplasms occurring in TPL patients were 2.3 times greater than in the matched subjects. In addition, TPL patients 50 years of age or older had an approximate 5.4-fold higher risk of developing advanced neoplasms than did the matched subjects (OR 5.370; 95 % CI 2.543–11.336; P < 0.001). Age and history of advanced neoplasms were associated with an increased risk of developing advanced neoplasms after TPL. The 5-year cumulative incidence rate of advanced neoplasms was 3.6 % in the 82 patients with normal or non-advanced adenomas detected via screening colonoscopy before TPL.

Conclusions

Colonoscopy is recommended for patients before and after kidney TPL, especially for those 50 years of age or older. Colonoscopy surveillance after TPL is warranted strictly according to the baseline risk stratification.
Literature
1.
go back to reference Abecassis M, Bartlett ST, Collins AJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) conference. Clin J Am Soc Nephrol. 2008;3:471–480.CrossRefPubMedCentralPubMed Abecassis M, Bartlett ST, Collins AJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) conference. Clin J Am Soc Nephrol. 2008;3:471–480.CrossRefPubMedCentralPubMed
2.
go back to reference Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med. 2000;343:404–410.CrossRefPubMed Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med. 2000;343:404–410.CrossRefPubMed
3.
go back to reference Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol. 2005;56:23–46.CrossRefPubMed Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol. 2005;56:23–46.CrossRefPubMed
4.
go back to reference Birkeland SA. Malignant tumors in renal transplant patients the scandia transplant material. Cancer. 1983;51:1571–1575.CrossRefPubMed Birkeland SA. Malignant tumors in renal transplant patients the scandia transplant material. Cancer. 1983;51:1571–1575.CrossRefPubMed
5.
go back to reference Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am. 1993;7:431–445.PubMed Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am. 1993;7:431–445.PubMed
6.
go back to reference Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.CrossRefPubMed Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.CrossRefPubMed
7.
go back to reference Bertario L, Russo A, Sala P, et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer. 2003;105:82–87.CrossRefPubMed Bertario L, Russo A, Sala P, et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer. 2003;105:82–87.CrossRefPubMed
8.
go back to reference Manser CN, Bachmann LM, Brunner J, Hunold F, Bauerfeind P, Marbet UA. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc. 2012;76:110–117.CrossRefPubMed Manser CN, Bachmann LM, Brunner J, Hunold F, Bauerfeind P, Marbet UA. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc. 2012;76:110–117.CrossRefPubMed
9.
go back to reference Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M, Group IMS. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–825.CrossRefPubMedCentralPubMed Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M, Group IMS. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–825.CrossRefPubMedCentralPubMed
10.
go back to reference Morelli MS, Glowinski EA, Juluri R, Johnson CS, Imperiale TF. Yield of the second surveillance colonoscopy based on the results of the index and first surveillance colonoscopies. Endoscopy. 2013;45:821–826.CrossRefPubMed Morelli MS, Glowinski EA, Juluri R, Johnson CS, Imperiale TF. Yield of the second surveillance colonoscopy based on the results of the index and first surveillance colonoscopies. Endoscopy. 2013;45:821–826.CrossRefPubMed
11.
go back to reference Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4:905–913.CrossRefPubMed Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4:905–913.CrossRefPubMed
12.
go back to reference Kiberd BA, Keough-Ryan T, Clase CM. Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant. 2003;3:619–625.CrossRefPubMed Kiberd BA, Keough-Ryan T, Clase CM. Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant. 2003;3:619–625.CrossRefPubMed
13.
go back to reference Saidi R, Dudrick P, Goldman M. Colorectal cancer after renal transplantation. Transplant Proc. 2003;35:1410–1412.CrossRefPubMed Saidi R, Dudrick P, Goldman M. Colorectal cancer after renal transplantation. Transplant Proc. 2003;35:1410–1412.CrossRefPubMed
14.
go back to reference Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296:2823–2831.CrossRefPubMed Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296:2823–2831.CrossRefPubMed
15.
go back to reference Park J, Choi MG, Kim S, et al. Increased incidence of colorectal malignancies in renal transplant recipients: a case control study. Am J Transplant. 2010;10:2043–2050.CrossRefPubMed Park J, Choi MG, Kim S, et al. Increased incidence of colorectal malignancies in renal transplant recipients: a case control study. Am J Transplant. 2010;10:2043–2050.CrossRefPubMed
16.
go back to reference Collins MG, Teo E, Cole SR, et al. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy. BMJ. 2012;345:e4657.CrossRefPubMedCentralPubMed Collins MG, Teo E, Cole SR, et al. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy. BMJ. 2012;345:e4657.CrossRefPubMedCentralPubMed
17.
go back to reference Ichikawa Y, Iida M, Ebisui C, et al. A case study of adult T-cell lymphoma in a kidney transplant patient. Transplant Proc. 2000;32:1982–1983.CrossRefPubMed Ichikawa Y, Iida M, Ebisui C, et al. A case study of adult T-cell lymphoma in a kidney transplant patient. Transplant Proc. 2000;32:1982–1983.CrossRefPubMed
18.
go back to reference Kasiske B, Danpanich E. Malignancies in renal transplant recipients. Transplant Proc. 2000;32:1499–1500.CrossRefPubMed Kasiske B, Danpanich E. Malignancies in renal transplant recipients. Transplant Proc. 2000;32:1499–1500.CrossRefPubMed
19.
go back to reference Parikshak M. The role of endoscopic colon surveillance in the transplant population. Dis Colon Rectum. 2002;45:1655–1660.CrossRefPubMed Parikshak M. The role of endoscopic colon surveillance in the transplant population. Dis Colon Rectum. 2002;45:1655–1660.CrossRefPubMed
20.
go back to reference Chung SJ, Kim YS, Yang SY, et al. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut. 2011;60:1537–1543.CrossRefPubMed Chung SJ, Kim YS, Yang SY, et al. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut. 2011;60:1537–1543.CrossRefPubMed
21.
go back to reference Rostaing L, Kamar N. mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field. J Nephrol. 2010;23:133–142.PubMed Rostaing L, Kamar N. mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field. J Nephrol. 2010;23:133–142.PubMed
22.
go back to reference Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding Ras: ‘it ain’t over’til it’s over’. Trends Cell Biol. 2000;10:147–154.CrossRefPubMed Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding Ras: ‘it ain’t over’til it’s over’. Trends Cell Biol. 2000;10:147–154.CrossRefPubMed
23.
go back to reference Kiaris H, Spandidos DA. Mutations of ras genes in human tumors (review). Int J Oncol. 1995;7:413–421.PubMed Kiaris H, Spandidos DA. Mutations of ras genes in human tumors (review). Int J Oncol. 1995;7:413–421.PubMed
24.
go back to reference Revuelta I, Moya-Rull D, García-Herrera A, et al. Role of oncogenic pathways and KRAS/BRAF mutations in the behavior of colon adenocarcinoma in renal transplant patients. Transplantation. 2012;93:509–517.CrossRefPubMed Revuelta I, Moya-Rull D, García-Herrera A, et al. Role of oncogenic pathways and KRAS/BRAF mutations in the behavior of colon adenocarcinoma in renal transplant patients. Transplantation. 2012;93:509–517.CrossRefPubMed
25.
go back to reference Chung SJ, Kim YS, Yang SY, et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40–49 years undergoing screening colonoscopy. J Gastroenterol Hepatol. 2010;25:519–525.CrossRefPubMed Chung SJ, Kim YS, Yang SY, et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40–49 years undergoing screening colonoscopy. J Gastroenterol Hepatol. 2010;25:519–525.CrossRefPubMed
26.
go back to reference Jung YS, Ryu S, Chang Y, et al. Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years. Gastrointest Endosc. Epub. 11/28/2014. Jung YS, Ryu S, Chang Y, et al. Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years. Gastrointest Endosc. Epub. 11/28/2014.
27.
go back to reference Rama I, Grinyó JM. Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol. 2010;6:511–519.CrossRefPubMed Rama I, Grinyó JM. Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol. 2010;6:511–519.CrossRefPubMed
Metadata
Title
Prevalence of Advanced Colorectal Neoplasm After Kidney Transplantation: Surveillance Based on the Results of Screening Colonoscopy
Authors
Jee Hye Kwon
Seong-Joon Koh
Ji Yeon Kim
Ji Won Kim
Kook Lae Lee
Byeong Gwan Kim
Jong Pil Im
Joo Sung Kim
Publication date
01-06-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3525-z

Other articles of this Issue 6/2015

Digestive Diseases and Sciences 6/2015 Go to the issue

UNM Clinical Case Conferences

An Intimate Cause of Proctocolitis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.